|
| 36599571 | ISCHEMIA Sheds Light on INOCA: Understanding Population Heterogeneity to Inform Prognosis and Guide Management. | JACC Cardiovasc Imaging | 2023 |
| 37821171 | Cardiac PET Perfusion Imaging: AURORA Lights the Way to a New Era. | J Am Coll Cardiol | 2023 |
| 36607538 | Quality metrics for single-photon emission computed tomography myocardial perfusion imaging: an ASNC information statement. | J Nucl Cardiol | 2023 |
| 33241477 | Beyond traditional cardiovascular risk factors: Could frailty and other morbidities explain the worse prognosis in patients undergoing pharmacologic stress? | J Nucl Cardiol | 2022 |
| 35550795 | ACR Appropriateness Criteria® Chronic Chest Pain-High Probability of Coronary Artery Disease: 2021 Update. | J Am Coll Radiol | 2022 |
| 36654806 | Beyond prediction: Off-target uses of artificial intelligence-based predictive analytics in a learning health system. | Learn Health Syst | 2022 |
| 35191316 | Long-Term Outcomes are Similar Despite Sex Disparities in High-Intensity Statin Use in Patients With Nonobstructive Coronary Artery Disease Diagnosed Via Invasive Coronary Angiography. | J Am Heart Assoc | 2022 |
| 35331658 | Cardiovascular Imaging for Ischemic Heart Disease in Women: Time for a Paradigm Shift. | JACC Cardiovasc Imaging | 2022 |
| 35022130 | Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population. | Am J Cardiol | 2022 |
| 34561848 | ASNC Imaging Indications (ASNC-I[2]): Multisocietal indications for radionuclide imaging in the multimodality context-Series rationale and methodology. | J Nucl Cardiol | 2022 |
| 34217819 | Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. | J Card Fail | 2022 |
| 32385831 | Heart rate response to vasodilator stress: A potential new application for a proven prognostic parameter. | J Nucl Cardiol | 2021 |
| 33521873 | Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging. | J Nucl Cardiol | 2021 |
| 33851351 | Transforming ATTR cardiac amyloidosis into a chronic disease: The enormous potential of quantitative SPECT to improve diagnosis, prognosis, and monitoring of disease progression. | J Nucl Cardiol | 2021 |
| 33865784 | Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction. | JACC Cardiovasc Imaging | 2021 |
| 33831085 | Lead aVR predicts early revascularization but not long-term events in patients referred for stress electrocardiography. | PLoS One | 2021 |
| 34043525 | Predictive Monitoring-Impact in Acute Care Cardiology Trial (PM-IMPACCT): Protocol for a Randomized Controlled Trial. | JMIR Res Protoc | 2021 |
| 34216037 | Long-term outcomes in patients with normal coronary arteries, nonobstructive, or obstructive coronary artery disease on invasive coronary angiography. | Clin Cardiol | 2021 |
| 34259978 | Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. | J Nucl Cardiol | 2021 |
| 34196911 | Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. | J Nucl Cardiol | 2021 |
| 34196222 | ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. | Circ Cardiovasc Imaging | 2021 |
| 34279803 | Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. | J Nucl Cardiol | 2021 |
| 31858426 | PAMA New Year's 2020: Did everything get brought to the party? | J Nucl Cardiol | 2021 |
| 30506155 | High-frequency QRS analysis to supplement ST evaluation in exercise stress electrocardiography: Incremental diagnostic accuracy and net reclassification. | J Nucl Cardiol | 2020 |
| 32671347 | Early Detection of In-Patient Deterioration: One Prediction Model Does Not Fit All. | Crit Care Explor | 2020 |
| 30051345 | A high exercise workload of â¿¥ 10 METS predicts a low risk of significant ischemia and cardiac events in older adults. | J Nucl Cardiol | 2020 |
| 31468377 | ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. | J Nucl Cardiol | 2020 |
| 31607665 | Cardiovascular Imaging Techniques to Assess Microvascular Dysfunction. | JACC Cardiovasc Imaging | 2020 |
| 31041679 | Regadenoson SPECT MPI post-troponin elevation in two different patient populations: A reliable risk-stratification tool. | J Nucl Cardiol | 2020 |
| 30788760 | Nuclear cardio-oncology: From its foundation to its future. | J Nucl Cardiol | 2020 |
| 30288679 | Coronary microvascular dysfunction: Filling the research gaps with careful patient selection. | J Nucl Cardiol | 2019 |
| 34552704 | Emerging Techniques for Cardiovascular PET. | Cardiovasc Innov Appl | 2019 |
| 31473268 | ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. | J Card Fail | 2019 |
| 31473267 | ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. | J Card Fail | 2019 |
| 31468376 | ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. | J Nucl Cardiol | 2019 |
| 31264115 | Functional and Anatomical Imaging in Patients with Ischemic Symptoms and Known Coronary Artery Disease. | Curr Cardiol Rep | 2019 |
| 27830435 | Combined non-invasive imaging for predicting cardiovascular events : Is three a crowd? | J Nucl Cardiol | 2018 |
| 29471856 | Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease. | J Cardiovasc Magn Reson | 2018 |
| 29720503 | Clinical Characteristics, Sex Differences, and Outcomes in Patients With Normal or Near-Normal Coronary Arteries, Non-Obstructive or Obstructive Coronary Artery Disease. | J Am Heart Assoc | 2018 |
| 29191566 | Usefulness of Achieving â¿¥10 METs With a Negative Stress Electrocardiogram to Screen for High-Risk Obstructive Coronary Artery Disease in Patients Referred for Coronary Angiography After Exercise Stress Testing. | Am J Cardiol | 2018 |
| 28585033 | Screening pre-renal transplant: Risk factors appear key but important questions remain. | J Nucl Cardiol | 2018 |
| 28545644 | Appropriate Referrals of Angiography Despite High Prevalence of Normal Coronary Arteries or Nonobstructive CAD. | J Am Coll Cardiol | 2017 |
| 28916938 | ASNC imaging guidelines for nuclear cardiology procedures : Standardized reporting of nuclear cardiology procedures. | J Nucl Cardiol | 2017 |
| 26694723 | Coronary Microvascular Dysfunction, Microvascular Angina, and Management. | Curr Cardiol Rep | 2016 |
| 26490266 | Prognostic impact of TID in regadenoson MPI: Some patients and certain events. | J Nucl Cardiol | 2016 |
| 26594908 | Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic Hypertension. | Cardiology | 2016 |
| 25677893 | Coronary microvascular dysfunction, microvascular angina, and treatment strategies. | JACC Cardiovasc Imaging | 2015 |
| 26563861 | Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies. | JACC Cardiovasc Imaging | 2015 |
| 26391501 | Screening asymptomatic patients with type 2 diabetes: The debates persist. | J Nucl Cardiol | 2015 |
| 25832984 | Contemporary relevance of TID: Based on the company it keeps. | J Nucl Cardiol | 2015 |